BAOLONG NGUYEN: Open Payments
NPI 1124795299 · SAN ANTONIO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$829 in 23 payments from 8 companies in 2025. Trend: 2023 $436 · 2024 $687 · 2025 $829
Food & beverage: $630Education: $199
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 7 | $194 |
| ABBVIE INC. | 5 | $184 |
| Lilly USA, LLC | 3 | $168 |
| Janssen Biotech, Inc. | 3 | $136 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 1 | $62 |
| Galderma Laboratories, L.P. | 1 | $48 |
| Novartis Pharmaceuticals Corporation | 1 | $26 |
| Organon LLC | 2 | $12 |
Products named: Sotyktu, RINVOQ, TREMFYA, EBGLYSS, Leqselvi, TALTZ, SKYRIZI, NEMLUVIO.
Industry payments across TX — which companies pay providers there.
